Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Allogeneic bone marrow transplantation].

H Shibata1

  • 1Center for Adult Disease, Osaka Laboratory Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene expression of angiotensin II receptor in blood cells of Cushing's syndrome.

Hypertension (Dallas, Tex. : 1979)·1995
Same author

Attenuation of glycogenolytic action of activin A in intact rat liver.

The American journal of physiology·1995
Same author

[Ictal electroencephalographic recordings of patients with seizure].

Rinsho byori. The Japanese journal of clinical pathology·1995
Same author

[Pharmacological and biochemical investigation of intracavital fluorinated pyrimidine chemotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy·1995
Same author

Expression of calcium-permeable cation channel CD20 accelerates progression through the G1 phase in Balb/c 3T3 cells.

The Journal of biological chemistry·1995
Same author

[Clinicopathological studies of anti-HCV P1P4 core antibody].

Rinsho byori. The Japanese journal of clinical pathology·1995
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Allogeneic stem cell transplant survival rates vary by leukemia type. Graft-versus-host disease (GVHD) may suppress leukemia relapse, while interstitial pneumonia is a major lethal complication. Prophylaxis strategies improve outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Context:

  • Allogeneic stem cell transplantation (SCT) is a critical treatment for various leukemias.
  • Long-term survival rates are influenced by leukemia type, graft-versus-host disease (GVHD), and complications.

Purpose:

  • To analyze long-term survival probabilities in allogeneic SCT recipients for acute lymphoblastic leukemia (ALL), acute non-lymphoblastic leukemia (ANL), and chronic myeloid leukemia (CML).
  • To investigate the impact of acute and chronic GVHD on survival and leukemia relapse rates.
  • To identify effective prophylaxis strategies against interstitial pneumonia and infections post-transplantation.

Summary:

  • Survival rates were 63% (ALL), 60% (ANL), and 47% (CML). Major causes of death included interstitial pneumonia, leukemia relapse, and infections.

Related Experiment Videos

  • Acute GVHD grades correlated with survival (38% for grade 0, 47% for grade I, 25% for grades II-IV).
  • Patients with both acute and chronic GVHD exhibited the lowest relapse rate (15.9%), suggesting a graft-versus-leukemia (GVL) effect. Interstitial pneumonia occurred in 32% of patients, with a 53% mortality rate. Effective prophylaxis included reduced total body irradiation, CMV-seronegative platelets, and anti-CMV globulin. Colony-stimulating factor shortened granulopenic periods.

    • Impact:

    • GVHD, particularly when both acute and chronic, may play a protective role against leukemia relapse (GVL effect).
    • Effective prophylaxis strategies are crucial for reducing mortality from complications like interstitial pneumonia and infections.
    • Optimizing GVHD management and prophylaxis can improve long-term survival outcomes for allogeneic SCT patients.